Meet us at the “Data Driven, Hybrid & Fully Decentralized Clinical Trials” Conference Our team will be at the “Data Driven, Hybrid & Fully Decentralized Clinical Trials” conference which is planned for April 16-17 in Philadelphia at the Hilton Philadelphia @Penns Landing. We’ll be at booth #1! RxE2 CEO Gerald Finken Joins Panel Discussion Gerald…
Join our session RxE2 CEO, Gerald Finken, will be taking part in a panel titled: “The Integration of Clinical Trials and Clinical Care: A Revolution in the Participant and Sponsor Experience or an Implementation Nightmare? Or Both?” When & Where Monday, October 23, 2023 | 7:00 AM – 9:00 AM ET | Location:308 AB West Meet…
For the second consecutive year we’ve made the list of best tech startups! The Tech Tribune staff has compiled a list of the best tech startups in North Dakota. Several factors were considered in their research, including but not limited to: Revenue potential Leadership team Brand/product traction Competitive landscape RxE2 is honored to have been…
Fargo, ND August 17 2023 – RxE2 announces the appointment of Doug Liberi as VP of Business Development and Sales. In his role as VP of business development, Mr. Liberi will be in charge of category creation and market expansion for RxE2, leading the company’s sales team strategically. “I am happy Doug has agreed to…
Fargo, ND, June 15, 2023 – This is the third year in which RxE2, led by CEO and two-time USA Cycling Masters National Cycling Champion, Gerald Finken, pledges $27,500 the NorthStar Cycling Club. “For over ten years NorthStar Development Cycling has shared the thrill of competitive cycling with scores of school-aged kids. Gerald Finken has…
RxE2 is disrupting the clinical supply chain to improve quality and eliminate waste – Meet us at #GCSG2023! Current supply chain logistics provide ample opportunity for risk and waste. What if we eliminate that? Led by Gerald E. Finken, the inventor of On-Demand Packaging & Labeling, RxE2 is de-risking the process by eliminating unnecessary steps for truly patient centric…
Our team will be in San Francisco during the J.P. Morgan Healthcare Conference and is ready to meet with investors and industry leaders. We will also be taking part in the First Analysis Healthcare Technology Conference – 2023. Reach out to Gerald Finken or to David Stark to schedule a meeting!
Fargo, ND, October 2022 RxE2 is happy to announce a recent investment from Badlands Capital. “I am so pleased to be working with Badlands Capital, especially since RxE2 is headquartered in Fargo, ND. The Badlands team truly understand what clinical trial innovation looks like and the magnitude of what RxE2 is and will accomplish, as we solve the recruitment, diversity,…
RxE2 is proud to be a member of the PQA, a non-profit organization with 250 diverse members across healthcare. Now more than ever we need to bring the practice of pharmacy into clinical trials. Incorporating PQA programs like Pharmacist Provided Care and Medication Use Quality will change the future outcomes for any clinical trial program…
We’ll be attending the annual meeting of NCPA in Kansas City, October 1 – 4. If you’re coming, let’s meet up! Our team on site will also be available at the CPESN USA booth #541 in the Exhibit Hall on Sunday, October 2, 2022 and on Monday, October 3, 2022 between 12:30 – 3:30 pm…